The effectiveness of pramipexole and cabergoline as an adjunct to levodopa in Parkinson's disease

被引：0
作者：
Oztekin, N.
Oztekin, M. F.
Sarl-Polat, R.
Orhan, G.
Ak, F.
机构：
来源：
PARKINSONISM & RELATED DISORDERS | 2007年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S106 / S107
页数：2
相关论文
共 50 条
[31]   Cost-effectiveness analysis of pramipexole in early Parkinson's disease [J].
Noyes, K ;
Dick, AW ;
Holloway, RG .
VALUE IN HEALTH, 2003, 6 (03) :274-274
[32]   A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy [J].
S. Pal ;
K. F. Bhattacharya ;
C. Agapito ;
K. Ray Chaudhuri .
Journal of Neural Transmission, 2001, 108 :71-77
[33]   A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy [J].
Pal, S ;
Bhattacharya, KF ;
Agapito, C ;
Chaudhuri, KR .
JOURNAL OF NEURAL TRANSMISSION, 2001, 108 (01) :71-77
[34]   Cost-effectiveness of pramipexole in Parkinson's disease in the United States [J].
Hoerger, TJ ;
Bala, MV ;
Rowland, C ;
Greer, M ;
Holloway, R .
NEUROLOGY, 1998, 50 (04) :A298-A299
[35]   Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson's disease [J].
Stocchi, F. ;
Rabey, J. M. .
EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 (12) :1373-1378
[36]   Ropinirole used as an adjunct to levodopa is effective on motor function in Parkinson's disease [J].
Oztekin, N. ;
Oztekin, M. F. ;
Dagdelen, F. ;
Acar, B. .
PARKINSONISM & RELATED DISORDERS, 2007, 13 :S107-S107
[37]   Cabergoline, pramipexole and ropinirole used as monotherapy in early Parkinson's disease - An evidence-based comparison [J].
Inzelberg, R ;
Schechtman, E ;
Nisipeanu, P .
DRUGS & AGING, 2003, 20 (11) :847-855
[38]   Efficacy, safety, and tolerability of pramipexole in untreated and levodopa-treated patients with Parkinson's disease [J].
Wong, KS ;
Lu, CS ;
Shan, DE ;
Yang, CC ;
Tsoi, TH ;
Mok, V .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 216 (01) :81-87
[39]   Evaluation of the Efficacy of Pramipexole for Treating Levodopa-induced Dyskinesia in Patients with Parkinson's Disease [J].
Utsumi, Hiroya ;
Okuma, Yasuyuki ;
Kano, Osamu ;
Suzuki, Yutaka ;
Iijima, Mutsumi ;
Tomimitsu, Hiroyuki ;
Hashida, Hideji ;
Kubo, Shin-ichiro ;
Suzuki, Masahiko ;
Nanri, Kazunori ;
Matsumura, Miyuki ;
Murakami, Hidetomo ;
Hattori, Nobutaka .
INTERNAL MEDICINE, 2013, 52 (03) :325-332
[40]   Cabergoline in the treatment of early Parkinson's disease: Results of the first year of treatment in a double-blind comparison of cabergoline and levodopa [J].
Rinne, UK ;
Bracco, F ;
Chouza, C ;
Dupont, E ;
Gershanik, O ;
Masso, JFM ;
Montastruc, JL ;
Marsden, CD ;
Dubini, A ;
Orlando, N ;
Grimaldi, R ;
Bergamasco, B ;
Mamoli, A ;
Scarpa, M ;
Scarano, M ;
Canal, N ;
Franceschi, M ;
Albanese, A ;
Bentivoglio, AR ;
Barone, P ;
Cicarelli, G ;
Malesani, R ;
Micheli, F ;
Muchnik, S ;
Pliego, L ;
Somoza, M ;
Gori, HE ;
Dominguez, R ;
Famulari, A ;
Aljanati, R ;
Mikkelsen, B ;
Olive, JM ;
Burguera, J ;
Miquel, F ;
GimenezRoldan, S ;
Mateo, D ;
Allain, H ;
Verin, M ;
Degos, JD ;
Destee, A ;
Warter, JM ;
Bernardi, F ;
Chillotti, C ;
Serra, JP ;
Garriga, MC ;
Benecke, R ;
Pirotta, RMN ;
Grossoni, M .
NEUROLOGY, 1997, 48 (02) :363-368
12345